- Buy Cheap Jaksta MAC
- Buy OEM Access 2010 All-in-One For Dummies
- Buy OEM Aimersoft DVD Backup MAC
- Buy OEM Incredible Bee Archiver 2 MAC
- Discount - Rosetta Stone - Learn Korean (Level 1, 2 & 3 Set)
- Buy Rosetta Stone - Learn French (Level 1, 2 & 3 Set) MAC (zh,en,fr,de,it,ja,ko,es)
- Download Chief Architect X2
- Discount - Adobe Creative Suite 6 Design Standard Student and Teacher Edition MAC
- 79.95$ Microsoft Windows XP Professional SP3 (32 bit) cheap oem
- 259.95$ Adobe Creative Suite 5.5 Production Premium cheap oem
- 29.95$ Infinite Skills - SolidWorks 2012 Advanced MAC cheap oem
- Discount - Adobe SoundBooth CS5
|The Business of Blood: How the Mississippi Valley Regional Blood Center Prepares for the Future|
|News/Features - Feature Stories|
|Written by Jeff Ignatius|
|Wednesday, 22 July 2009 08:25|
Page 1 of 2
When he got started in blood banks almost 20 years ago, David R. Green's understanding of the blood-transfusion process wasn't very sophisticated. Green, now the president and CEO of the Mississippi Valley Regional Blood Center, had a background in finance.
"I thought they simply took that bag of blood after they tested it and made sure that it was hanging above the patient, and it just flowed back in the patient," Green said last week. "I really didn't know."
Now Green runs an organization that last year collected more than 133,000 units of blood products, serves 53 hospitals in four states, and had more than $38 million in revenue in 2008. The organization's 72,000-square-foot building off 53rd Street in northeastern Davenport suggests a big operation, but few people realize just how large, or the complexity of the issues the blood-donation community deals with.
"The core of it is making sure the donors are safe, and that the product that goes out the back door is safe for recipients," said Dr. Louis Katz, the center's executive vice president for medical affairs.
The Mississippi Valley Regional Blood Center is trying to optimize - and therefore drive down - blood usage by hospitals; it is working to help identify heretofore poorly understood risks associated with blood transfusion; and Katz is among those preparing for the next disease threat to the blood supply. And the organization's size has the key benefit of keeping costs lower for local hospitals.
So it's not just bags of blood.
Less Is More
Because the blood center gets paid by hospitals only for blood products that are actually transfused, it's counterintuitive that the blood center is trying to get hospitals to lower usage.
There are two factors at work here: There is a limited supply of blood products available for transfusion, and there might be long-term adverse reactions to blood transfusion that have not yet been identified or are not yet fully understood.
"What that comes down to most recently is talking to clinicians about using less blood," Katz said.
The actual goal is optimization, which will result in lower blood usage. To that end, the Mississippi Valley Regional Blood Center began auditing its hospitals' transfusions last fall.
"If a hospital and their physician community are already at best practices, then no reduction in utilization happens," said Margaret M. Starkey, a utilization specialist with the center.
One study found that in the intensive-care unit, an effectively conservative approach to blood transfusion entails transfusing only when the hemoglobin drops below seven grams per deciliter. "Transfusing conservatively was at least equivalent in terms of clinical outcomes ... ," Katz said. "All the trends said conservative transfusion was better - safer."
Yet in an audit of one hospital's transfusion practices, 95 percent of ICU transfusions occurred above that level. "This hospital is not unique, by the way," Katz said.
There are no hard-and-fast rules for blood transfusions, and each medical situation must be considered individually, but Katz said a conservative approach would generally serve both patients and hospitals well. The hope is that presented with the transfusion patterns of their doctors and other facilities, hospitals would at least change the behavior of outliers - the doctors ordering transfusions most aggressively. "The blood center's job isn't just to be a dairy," Katz said. "It's to get information to the hospitals so that they understand what they need to do."
In most cases, Katz said, doctors who aggressively order transfusions are simply practicing medicine the way their were taught. "Habit's the biggest thing," Katz said. "It's how they were trained."
In other situations, he said, there might be good reasons doctors transfuse earlier than the guidelines suggest.
"The ultimate goal is to enhance patient safety," Starkey said. "Any time you have an invasive procedure, you have a risk."
She said earlier this month that 10 audits are in some stage of completion. While transfusion audits are not required or even common practice, she said, the Joint Commission - a private accrediting body for health-care organizations - is expected to set quality standards for transfusions in the coming years.
Another appeal of audits for hospitals served by the Mississippi Valley Regional Blood Center is that they spend less money on blood products. Because insurance companies generally pay a certain amount per procedure, using less blood during a procedure saves money.
"Cost containment really is a secondary gain," Starkey said. "Any time you avoid an unnecessary procedure, the patient's avoiding an unnecessary cost."
Reducing usage also has the benefit of ensuring that there's an adequate blood supply.
There's presently no shortage of blood, although the supply fluctuates seasonally. The 2007 National Blood Collection & Utilization Survey Report found that collected whole-blood and red-blood-cell units exceeded the number of transfused units by 7.8 percent. "These data, combined with the lowest rate of units outdated [past the date when they can be used] in recent years, suggest that hospitals and blood centers continue to improve efficiencies in delivering the appropriate product when needed," the report states. (Different blood products have different shelf lives. Whole blood, for example, expires after six weeks, while platelets last less than a week.)
And since this past winter, "the blood supply is actually quite flush ... ," Katz said.
But with the Baby Boomer generation getting older and living longer, there's likely to be a greater need for blood transfusions in the coming years and decades. "We feel we need to get into place the right processes to support that," Starkey said.
Katz added that it's also more difficult to get younger people to become donors. "It's much harder to get a Gen X or a Gen Y [person] ... into the blood center as a regular donor than it was my parents' generation," he said.
One challenge with blood donation is the number of "deferrals"; America's Blood Centers estimates that only 38 percent of people are eligible to donate blood. For example, men who have had sex with men since 1977 have a lifetime deferral. People who spent six months or more in the United Kingdom between 1980 and 1996 get a permanent deferral because of "mad cow disease." People with hemoglobin below a certain level get a temporary deferral.
Some deferrals meant to protect the blood supply are easily justified - there is no blood test for mad-cow disease, for instance - but others have been questioned. Since 1997, the American Association of Blood Banks has supported relaxing the male-to-male-sexual-contact deferral to one year. In a statement to the Food & Drug Administration in 2000, it said: "Modifying the deferral time period for male to male sexual contact to 12 months will make that deferral period consistent with the deferral period for other potentially high-risk sexual exposures and will improve the clarity and consistency of the donor screening questions. The potential donor will be directed to focus on recent, rather than remote risk behaviors and should have better recall for answers to the screening questions."
Because of the accuracy of HIV testing, Katz said, a one-year male-to-male-sexual-contact deferral would result in one transfusion-transmitted-HIV case every 17 to 58 years.
But the Food & Drug Administration hasn't relented. Its response, Katz said, is that "we cannot add risk to the system."